Skip to search formSkip to main contentSkip to account menu

AIEOP protocol 8202

Known as: AIEOP 8833 protocol, Italian Hematology and Pediatric Oncology Association protocol 8202, intermediate risk ALL 8202 protocol 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (7)

ASPARAGINASEAntineoplastic Combined Chemotherapy ProtocolsDaunorubicinMethotrexate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Infezioni Clinicamente rilevanti durante la terapia di induzione sono associate con un aumento del rischio di recidiva. Studio di 1999 pazienti arruolati nel protocollo AIEOP-LLA-2000.
2014
2014
I percorsi di assistenza ai bambini guariti da tumore: L'esperienza dei centri AIEOP
2012
2012
Protocolli AIEOP MH’83-89-96 per la terapia del linfoma di Hodgkin (lh) in età pediatrica. Sopravvivenza a lungo termine e seconde neoplasie maligne.
2007
2007
DNA index has prognostic value of LLA in children treated with BFM type intense chemotherapy. Final protocol results AIEOP-LLA-94
2002
2002
TUMORI a CELLULE GERMINALIin ETA' PEDIATRICA: FATTORI PROGNOSTICI del PROTOCOLLO AIEOP TCG 91.
1993
1993
IL RUOLO DELLA CHIRURGIA NEL TRATTAMENTO DEI TUMORI GERMINALI IN ETA' PEDIATRICA: Analisi dello Studio Cooperativo "AIEOP TCG-'91.
Review
1991
Review
1991
ABMT for children AML: Italian experience. GITMO-AIEOP Groups.
We report data from an Italian survey on ABMT in 93 AML children less than 14 years in 1st or 2nd remission performed in 15… 
1984
1984
Early deaths in acute lymphoblastic leukemia (ALL): results of the Italian Pediatric Cooperative Group for Therapy of Acute Leukemia (AIL-AIEOP).
In this retrospective multicentric study, we report on early deaths (ie, those that occurred during the first month of treatment…